Rapid Clearance of Psoriatic Skin Lesions Induced by Topical Cyclopamine
- 1 August 2004
- journal article
- research article
- Published by S. Karger AG in Dermatology
- Vol. 209 (2) , 126-131
- https://doi.org/10.1159/000079596
Abstract
We have earlier found a highly efficient induction of the differentiation of epidermal lineage skin tumors by cyclopamine, a steroidal alkaloid inhibitor of the hedgehog/smoothened signaling, under conditions in which cyclopamine exerted no adverse effect on skin. We aimed to develop a mechanism-based treatment for psoriasis with cyclopamine. We subjected psoriatic skin lesions to cyclopamine under conditions similar to those we used for skin tumors and evaluated the responses of lesions clinically and by histopathological/immunohistochemical analyses. All treated lesions in different patients having plaque and guttate forms of psoriasis regressed rapidly. Differentiation of the epidermal cells of lesional skin and disappearances of infiltrating inflammatory cells were evident within a day. Lesions were cleared commonly on days 3-4. Former treatment sites followed up for more than 24 months now show a lack of adverse effects in the long term. An effective treatment for psoriasis is described, consistent with intervention in a proximal/key pathogenic event.Keywords
This publication has 7 references indexed in Scilit:
- Combination of calcipotriene (Dovonex) ointment and tazarotene (Tazorac) gel versus clobetasol ointment in the treatment of plaque psoriasis: A pilot studyJournal of the American Academy of Dermatology, 2002
- The immunologic basis for the treatment of psoriasis with new biologic agentsJournal of the American Academy of Dermatology, 2002
- Hedgehog acts as a somatic stem cell factor in the Drosophila ovaryNature, 2001
- Hedgehog Signaling Regulates Differentiation from Double-Negative to Double-Positive ThymocyteImmunity, 2000
- Clearance is not a realistic expectation of psoriasis treatmentJournal of the American Academy of Dermatology, 2000
- Expression of E-cadherin, α- & β-catenin, and CD44V6 and the subcellular localization of E-cadherin and CD44V6 in normal epidermis and basal cell carcinomaHuman Pathology, 1999
- Teratogen-Mediated Inhibition of Target Tissue Response to Shh SignalingScience, 1998